Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has reported a significant change in share ownership, with Van Lanschot Kempen Investment Management NV acquiring a decreased total voting rights percentage of 3.704483%, amounting to 20,019,017 voting rights, as of 13th June 2024. The notification, completed on 17th June 2024 in Amsterdam, reflects a shift from the previous notification where the investment firm held a higher percentage of 4.827550%.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
